Litcius/Paper detail

Circular RNA PPP1CC promotes <i>Porphyromonas gingivalis</i> -lipopolysaccharide-induced pyroptosis of vascular smooth muscle cells by activating the HMGB1/TLR9/AIM2 pathway

Jie Liu, Yong Wang, Yaoyun Liao, Ying Zhou, Zhu Ji-jin

2021Journal of International Medical Research26 citationsDOIOpen Access PDF

Abstract

Objective Porphyromonas gingivalis ( Pg) plays a critical role in the occurrence and development of atherosclerosis. Lipopolysaccharide from Pg ( Pg-LPS) could lead to pyroptosis of vascular smooth muscle cells (VSMCs) and induce instability of atherosclerotic plaque. Therefore, pyroptosis of VSMCs could promote the process of atherosclerosis. However, the exact mechanism of Pg-LPS-induced pyroptosis of VSMCs is unclear. Methods We determined pyroptosis and expression of interleukin (IL)-1β and IL-18 in VSMCs using 4′,6-diamidino-2-phenylindole staining and ELISA after stimulation by Pg-LPS. We established a knockdown plasmid containing the circular (circ)RNA PPP1CC and transfected it into VSMCs. Luciferase assays were performed to reveal the association between microRNAs miR-103a-3p and miR-107 and circRNA PPP1CC. Results Stimulation of Pg-LPS led to pyroptosis of VSMCs. Knockdown of circRNA PPP1CC relieved the Pg-LPS-induced pyroptosis of VSMCs and suppressed the expression of HMGB1, TLR9, AIM2, and cleaved caspase-1. Luciferase assays showed that PPP1CC directly targeted and competitively adsorbed miR-103a-3p and miR-107, weakening the inhibitory effect of these microRNAs on the expression of HMGB1. Conclusion Knockdown of circRNA PPP1CC relieved Pg-LPS-induced pyroptosis of VSMCs. Pyroptosis of VSMCs appears to promote atherosclerosis and may represent a novel therapeutic target for its treatment.

Topics & Concepts

PyroptosisGene knockdownVascular smooth muscleCell biologyTransfectionmicroRNAProinflammatory cytokineLipopolysaccharideCaspase 1InflammasomeMolecular biologyChemistryInflammationMedicineBiologyApoptosisImmunologyBiochemistryEndocrinologyGeneSmooth muscleCircular RNAs in diseasesInflammasome and immune disordersMicroRNA in disease regulation